R7	Coref Anaphora:T13 Antecedent:T38
R8	Coref Anaphora:T19 Antecedent:T39
R9	Coref Anaphora:T25 Antecedent:T40
R10	Coref Anaphora:T27 Antecedent:T41
R11	Coref Anaphora:T31 Antecedent:T42
R12	Coref Anaphora:T34 Antecedent:T11
T1	Protein 46 50	CD28
T2	Protein 79 92	interleukin-2
T3	Protein 118 131	interleukin-2
T4	Protein 264 268	CD28
T5	Protein 304 317	interleukin-2
T6	Protein 319 323	IL-2
T7	Protein 385 389	IL-2
T8	Protein 433 437	CD28
T9	Protein 1041 1045	CD28
T10	Protein 1289 1293	IL-2
T11	Protein 1471 1475	IL-2
T12	Protein 1572 1576	IL-2
T38	Exp 22 30	a factor
T39	Exp 456 462	CD28RE
T40	Exp 773 782	NF-MATp35
T41	Exp 950 957	T cells
T42	Exp 1057 1088	Nonmitogenic T cell stimulation
T13	Exp 31 35	that
T14	Exp 42 67	the CD28 response element
T15	Exp 75 101	the interleukin-2 enhancer
T16	Exp 182 204	the combined signaling
T17	Exp 208 227	the T cell receptor
T18	Exp 270 281	The ability
T19	Exp 464 468	that
T20	Exp 381 398	The IL-2 enhancer
T21	Exp 536 555	The CD28RE sequence
T22	Exp 578 612	the consensus kappaB binding motif
T23	Exp 619 621	we
T24	Exp 634 638	that
T25	Exp 784 788	that
T26	Exp 815 827	the known NF
T27	Exp 958 962	that
T28	Exp 1155 1159	that
T29	Exp 1230 1239	the level
T30	Exp 1132 1145	These results
T31	Exp 1275 1285	its effect
T32	Exp 1330 1343	the induction
T33	Exp 1397 1401	that
T34	Exp 1488 1493	which
T35	Exp 1402 1424	the nuclear appearance
T36	Exp 1557 1568	the control
T37	Exp 1374 1384	these data
